Showing results (131-140 of 178) with videos related to
Sort By:
Pageof 18
Respiratory Research|November 1, 2019
Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)James F Donohue, Edward Kerwin, Sanjay Sethi, et al.International Journal of Chronic Obstructive Pulmonary Disease|August 31, 2016
Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study designStephen I Rennard, Fernando J Martinez, Klaus F Rabe, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 28, 2010
Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measureNancy Kline Leidy, Teresa K Wilcox, Paul W Jones, et al.Respiratory Research|October 8, 2014
Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trialsNancy K Leidy, Lindsey T Murray, Brigitta U Monz, et al.Respiratory Medicine|April 20, 2026
Outcomes of Patients with COPD Before and After Initiation of Treatment with Budesonide/Glycopyrrolate/Formoterol Fumarate: Results from the US ARCTOS StudySanjay Sethi, Laurence Gozalo, Donna McMorrow, et al.Journal of Managed Care & Specialty Pharmacy|May 3, 2023
Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterolSanjay Sethi, Swetha R Palli, Lindsay G S Bengtson, et al.Annals of the American Thoracic Society|January 16, 2014
Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary diseaseHimanshu Desai, Karen Eschberger, Catherine Wrona, et al.American Journal of Respiratory and Critical Care Medicine|January 31, 2009
Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profileGordon J Gaschler, Marko Skrtic, Caleb C J Zavitz, et al.Respiratory Research|August 11, 2017
A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary diseasePeter M A Calverley, Sanjay Sethi, Michelle Dawson, et al.Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Proteomic Network Analysis of Bronchoalveolar Lavage Fluid in Ex-Smokers to Discover Implicated Protein Targets and Novel Drug Treatments for Chronic Obstructive Pulmonary DiseaseManoj J Mammen, Chengjian Tu, Matthew C Morris, et al.Pageof 18